710 related articles for article (PubMed ID: 9301046)
1. Photodynamic therapy with 5-aminolaevulinic acid-induced porphyrins of an amelanotic melanoma in vivo.
Abels C; Fritsch C; Bolsen K; Szeimies RM; Ruzicka T; Goerz G; Goetz AE
J Photochem Photobiol B; 1997 Aug; 40(1):76-83. PubMed ID: 9301046
[TBL] [Abstract][Full Text] [Related]
2. Porphyrins preferentially accumulate in a melanoma following intravenous injection of 5-aminolevulinic acid.
Fritsch C; Abels C; Goetz AE; Stahl W; Bolsen K; Ruzicka T; Goerz G; Sies H
Biol Chem; 1997 Jan; 378(1):51-7. PubMed ID: 9049065
[TBL] [Abstract][Full Text] [Related]
3. In vivo kinetics and spectra of 5-aminolaevulinic acid-induced fluorescence in an amelanotic melanoma of the hamster.
Abels C; Heil P; Dellian M; Kuhnle GE; Baumgartner R; Goetz AE
Br J Cancer; 1994 Nov; 70(5):826-33. PubMed ID: 7947087
[TBL] [Abstract][Full Text] [Related]
4. Photodynamic therapy with 5-aminolevulinic acid induces distinct microcirculatory effects following systemic or topical application.
Schacht V; Szeimies RM; Abels C
Photochem Photobiol Sci; 2006 May; 5(5):452-8. PubMed ID: 16685321
[TBL] [Abstract][Full Text] [Related]
5. Simulations on the selectivity of 5-aminolaevulinic acid-induced fluorescence in vivo.
Ackermann G; Abels C; Bäumler W; Langer S; Landthaler M; Lang EW; Szeimies RM
J Photochem Photobiol B; 1998 Dec; 47(2-3):121-8. PubMed ID: 10093911
[TBL] [Abstract][Full Text] [Related]
6. The influence of the vehicle on the synthesis of porphyrins after topical application of 5-aminolaevulinic acid. Implications in cutaneous photodynamic sensitization.
Casas A; Fukuda H; Di Venosa G; Batlle AM
Br J Dermatol; 2000 Sep; 143(3):564-72. PubMed ID: 10971330
[TBL] [Abstract][Full Text] [Related]
7. Targeting of the tumor microcirculation by photodynamic therapy with a synthetic porphycene.
Abels C; Szeimies RM; Steinbach P; Richert C; Goetz AE
J Photochem Photobiol B; 1997 Oct; 40(3):305-12. PubMed ID: 9372621
[TBL] [Abstract][Full Text] [Related]
8. Experimental photodynamic therapy with MESO-tetrakisphenylporphyrin (TPP) in liposomes leads to disintegration of human amelanotic melanoma implanted to nude mice.
Jezek P; Nekvasil M; Skobisová E; Urbánková E; Jirsa M; Zadinová M; Poucková P; Klepácek I
Int J Cancer; 2003 Feb; 103(5):693-702. PubMed ID: 12494481
[TBL] [Abstract][Full Text] [Related]
9. A comparative study of tissue distribution and photodynamic therapy selectivity of chlorin e6, Photofrin II and ALA-induced protoporphyrin IX in a colon carcinoma model.
Orenstein A; Kostenich G; Roitman L; Shechtman Y; Kopolovic Y; Ehrenberg B; Malik Z
Br J Cancer; 1996 Apr; 73(8):937-44. PubMed ID: 8611429
[TBL] [Abstract][Full Text] [Related]
10. In vivo fluorescence kinetics and photodynamic therapy efficacy of delta-aminolevulinic acid-induced porphyrins in basal cell carcinomas and actinic keratoses; implications for optimization of photodynamic therapy.
Stefanidou M; Tosca A; Themelis G; Vazgiouraki E; Balas C
Eur J Dermatol; 2000; 10(5):351-6. PubMed ID: 10882942
[TBL] [Abstract][Full Text] [Related]
11. Influence of topical photodynamic therapy with 5-aminolevulinic acid on porphyrin metabolism.
Fritsch C; Verwohlt B; Bolsen K; Ruzicka T; Goerz G
Arch Dermatol Res; 1996 Aug; 288(9):517-21. PubMed ID: 8874745
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of delta-aminolevulinic acid-induced protoporphyrin as a photosensitizer for photodynamic therapy in vivo.
Hua Z; Gibson SL; Foster TH; Hilf R
Cancer Res; 1995 Apr; 55(8):1723-31. PubMed ID: 7712481
[TBL] [Abstract][Full Text] [Related]
13. Tissue distribution and penetration of 5-ALA induced fluorescence in an amelanotic melanoma after topical application.
Pahernik S; Langer S; Botzlar A; Dellian M; Goetz AE
Anticancer Res; 2001; 21(1A):59-63. PubMed ID: 11299790
[TBL] [Abstract][Full Text] [Related]
14. Effects of light fractionation and different fluence rates on photodynamic therapy with 5-aminolaevulinic acid in vivo.
Babilas P; Schacht V; Liebsch G; Wolfbeis OS; Landthaler M; Szeimies RM; Abels C
Br J Cancer; 2003 May; 88(9):1462-9. PubMed ID: 12778078
[TBL] [Abstract][Full Text] [Related]
15. Evidence for a bystander role of neutrophils in the response to systemic 5-aminolevulinic acid-based photodynamic therapy.
de Bruijn HS; Sluiter W; van der Ploeg-van den Heuvel A; Sterenborg HJ; Robinson DJ
Photodermatol Photoimmunol Photomed; 2006 Oct; 22(5):238-46. PubMed ID: 16948825
[TBL] [Abstract][Full Text] [Related]
16. Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts.
Peng Q; Warloe T; Moan J; Godal A; Apricena F; Giercksky KE; Nesland JM
Cancer Res; 2001 Aug; 61(15):5824-32. PubMed ID: 11479222
[TBL] [Abstract][Full Text] [Related]
17. Intracutaneous ALA photodynamic therapy: dose-dependent targeting of skin structures.
Sakamoto FH; Doukas AG; Farinelli WA; Tannous Z; Su Y; Smith NA; Zurakowski D; Anderson RR
Lasers Surg Med; 2011 Sep; 43(7):621-31. PubMed ID: 22057490
[TBL] [Abstract][Full Text] [Related]
18. Delivery of a hydrophobic phthalocyanine photosensitizer using PEGylated gold nanoparticle conjugates for the in vivo photodynamic therapy of amelanotic melanoma.
Camerin M; Moreno M; Marín MJ; Schofield CL; Chambrier I; Cook MJ; Coppellotti O; Jori G; Russell DA
Photochem Photobiol Sci; 2016 May; 15(5):618-25. PubMed ID: 27064601
[TBL] [Abstract][Full Text] [Related]
19. Sustained and efficient porphyrin generation in vivo using dendrimer conjugates of 5-ALA for photodynamic therapy.
Casas A; Battah S; Di Venosa G; Dobbin P; Rodriguez L; Fukuda H; Batlle A; MacRobert AJ
J Control Release; 2009 Apr; 135(2):136-43. PubMed ID: 19168101
[TBL] [Abstract][Full Text] [Related]
20. Photodynamic therapy using 5-aminolaevulinic acid for experimental pancreatic cancer--prolonged animal survival.
Regula J; Ravi B; Bedwell J; MacRobert AJ; Bown SG
Br J Cancer; 1994 Aug; 70(2):248-54. PubMed ID: 8054272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
